Cardiovascular Diseases Research in Virginia
Cardiovascular Diseases Research (93.837) awarded $278 million to recipients in Virginia in 240 grants from fiscal 2021 to 2025, 1.9% of the program's national total. Rector & Visitors of the University of Virginia received the most, $186 million.
- Awarded in Virginia$278 million
- Awards240
- Share of the program1.9%
- Rank among states20th of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 104 | $48.2 million |
| FY 2022 | 114 | $51.8 million |
| FY 2023 | 113 | $56.0 million |
| FY 2024 | 119 | $60.4 million |
| FY 2025 | 113 | $62.1 million |
Recipients in Virginia
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Rector & Visitors of the University of Virginia | Colleges and universities | 134 | $186 million |
| Virginia Commonwealth University | Colleges and universities | 40 | $34.2 million |
| Virginia Polytechnic Institute & State University | Colleges and universities | 26 | $20.4 million |
| Old Dominion University | Colleges and universities | 5 | $5.8 million |
| Illexcor Therapeutics, Inc. | Small businesses | 3 | $5.0 million |
| Old Dominion University | Nonprofits | 4 | $4.6 million |
| Barron Associates, Inc. | Small businesses | 2 | $3.8 million |
| Nour Heart Inc | Small businesses | 1 | $3.6 million |
| Inova Health Care Services | Nonprofits | 4 | $2.7 million |
| Sentara Health | Nonprofits | 1 | $2.6 million |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 82 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Virginia?
$278 million from fiscal 2021 to 2025, across 240 awards. Virginia ranks 20th of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Virginia?
The largest recipient is Rector & Visitors of the University of Virginia, with $186 million in 134 awards. Next are Virginia Commonwealth University and Virginia Polytechnic Institute & State University.
Can organizations in Virginia apply now?
Yes, 82 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Virginia
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Broadband Equity, Access, and Deployment Program
- Emergency Food and Shelter National Board Program